# Kisspeptin discovery and puberty genetics

> How kisspeptin was discovered | Ripple Peptides — Ripple Peptides follows KISS1 from melanoma cells and mice to human puberty genetics, including a receptor whose response lasted longer.

**1**

The reproductive story began somewhere unexpected: experiments on the spread of melanoma.

## Melanoma experiments, 1996

My first mental picture of kisspeptin was entirely reproductive. Its origin made that picture much less tidy. In [the melanoma experiments reported in 1996](https://pubmed.ncbi.nlm.nih.gov/8944003/), introducing the KISS1 gene into metastatic human melanoma cells suppressed metastasis in nude mice while leaving the cells capable of forming tumours. The distinction between forming a tumour and spreading to another site was central to the result.

This was work with a human cell line and a mouse model. The finding concerned a gene introduced into cells, with metastasis as the outcome. A therapeutic legend built from this origin would lose me immediately: the actual experimental arrangement is strange and interesting enough. It also explains why a search through kisspeptin's history runs into cancer biology before it reaches reproductive hormones.

![Two illustrated researchers discuss a culture dish beside an inverted microscope.](images/cell-culture-bench.webp)

*An illustrative cell-culture scene inspired by the early melanoma experiments; no named person or laboratory is depicted.*

## Puberty genetics, 2003

The reproductive connection became much harder to dismiss with [the GPR54 loss-of-function findings](https://pubmed.ncbi.nlm.nih.gov/14573733/). GPR54 is also called KISS1R, the kisspeptin receptor. In the affected human family, loss of receptor function was associated with failure of puberty and low LH and FSH; mice lacking the receptor reproduced the phenotype.

I give this evidence particular weight because the disturbance starts at a specific biological component and has a profound reproductive consequence. It supplies a different kind of argument from administering a peptide and observing a temporary hormone rise. The human genetics and the mouse findings support each other while remaining distinct parts of the investigation.

## Prolonged receptor signaling, 2008

The opposite disturbance adds a revealing wrinkle. Researchers identified [an activating GPR54 mutation in a girl with central precocious puberty](https://pubmed.ncbi.nlm.nih.gov/18272894/). In vitro, the altered receptor showed prolonged responsiveness to kisspeptin. The human finding concerned early pubertal activation; the prolonged receptor response was measured in the laboratory.

Duration is already doing important work in this story. I think the unusually persistent response is more illuminating than the vague idea of a stronger signal. It puts a question about timing inside the receptor itself, long before the discussion reaches experimental administration.

## The KISS1 gene, 2012

A later family study identified [an inactivating mutation in KISS1 itself](https://pubmed.ncbi.nlm.nih.gov/22335740/), with hypogonadotropic hypogonadism and pubertal failure in homozygous carriers. This brought the peptide's own gene into the human genetic evidence, alongside the earlier receptor findings.

Together, these studies redrew kisspeptin for me as something more fundamental than a peptide with a reproductive application: a signaling system whose disruption can alter reproductive maturation. The next essay moves from those inherited disturbances to [the timing of experimentally evoked hormone pulses](/pulse).

---

At Ripple Peptides I follow kisspeptin through the published experiments and argue over the consequences, with essays to think about rather than medical advice to act on.